Search legislation

Most Recent Comments

1) Bill risks womens lives and has patent issues  by Anonymous Citizen on July 21, 2006 
Patents are what is hurting hES research.

This is a terrible bill which puts women's health at risk - up to death - to supply research materials for pharmaceutical industry.

Human embryonic stem cell (hESC) research requires eggs ... millions of them, hundreds of millions if we include cloning.

There are not 400,000 embryos 'available for research' and anyone who tells you different is ill informed or a liar. The study from which the number come is at: http://www.rand.org/news/press.03/05.08.html

My testimony explains the cost to women and viable alternatives and can be found at the the house website (gaffney) - or w/live links to sources at: http://www.stemcellscure.info.

Testimony of esearcher, Sean Morrison, is at:
http://www.holtbiz.com/StemCells/UofM.htm

Though he supports the bill, his testimony confirms that you have to clone to use therapies (something we are unable to do in any apes and may not for biological reasons ... there aren't enough women to supply the eggs.) and sets the stage to exploit poor women of color in order to 'diversify'.

In countries limiting to clinic embryos - they find there aren't enough embryos. If they deny payments - they get no donors. If they have low payments - they go to countries where $300 is a month/years wages.

This bill puts womens lives at risk for research that has not been completed on animals; is unlikely to produce reparative therapies; is unlikely to have insurance pay (except for the drugs); and is impaired by patent restrictions.

http://www.contracostatimes.com/mld/cctimes/news/nation/15071860.htm


Reply

2) 2006 Senate Bill 1345 (Repeal embryonic stem cell research ban )  by admin on January 1, 2001 
Introduced in the Senate on June 28, 2006

Click here to view bill details.
Reply

View Full Conversation